GIMAP5 and autoimmune disease: Such a dysregulation may be occurring in autoimmune diseases associated with pathogenic Th17 cells, such as Crohn’s disease, T1D, and multiple sclerosis69–71, or in Gimap5-associated diseases such as SLE, T1D, and allergic asthma1–4.